A systematic review of minimally invasive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal malignancy.

Lauren CohenFaizah AlamMichael P Flood Helen M Mohan Anshini Jain Glen R Guerra Alexander G Heriot Joseph Cherng Huei Kong

Published in: ANZ journal of surgery (2024)

Minimally invasive CRS and HIPEC appears feasible and safe in appropriately selected patients. Clear histological stratification and longer term follow up is required to determine oncological safety, particularly in more aggressive tumours such as colorectal peritoneal metastases.

Keyphrases

minimally invasive
robot assisted
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
preterm infants
prostate cancer
squamous cell carcinoma
locally advanced
radiation therapy
radical prostatectomy
coronary artery disease
surgical site infection